Oncology

Modern-Era Follow-Up Strategies for Detecting Recurrent Breast Cancer

The standard follow-up protocol for treated breast cancer patients continues to be the recommended and currently relevant surveillance strategy. Breast cancer patients who undergo surgery and adjuvant therapy require follow-up to detect recurrent disease or any long-term complications and improve their survival and outcomes. The standard follow-up protocol in these patients is based on studies...

ChatGPT: A Tool for Radiation Oncology Education and Decision-Making

Staff Writer: Deileta Kamhunga A new study shows the potential of large language models in radiation oncology education and decision-making. A recent preprint made available on April 24th has shown that large language models such as chat generative pre-training transformer (ChatGPT)-3.5 and ChatGPT-4 have the potential to be useful tools in radiation oncology education and...

DDW: Lower Risk for Obesity-Linked Cancer Seen With Bariatric Surgery

Prevalence rates lower for de novo breast cancer, colon cancer, liver cancer, pancreatic cancer, ovarian cancer, endometrial cancer. Bariatric surgery is associated with a reduction in the risk for obesity-associated cancers, according to a study to be presented at the 2023 Digestive Disease Week, being held from May 6 to 9 in Chicago.   Vibhu...

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Multiple Myeloma

Daratumumab with bortezomib and dexamethasone significantly increased the overall survival in patients suffering from relapsed or refractory multiple myeloma. Daratumumab is a human monoclonal CD38 antibody that poses greater cytotoxicity against multiple myeloma cells than other CD38 antibodies. Adding this drug to the standard treatment regimen for multiple myeloma significantly improves the durability of response...

Novel B-Cell Maturation Antigen for Relapsed and Refractory Multiple Myeloma

This phase 1 study demonstrated that chimeric antigen receptor T completely synthetic antigen-binding domain cell therapy is safe and has a durable response in patients with relapsed and refractory multiple myeloma. Relapsed and refractory multiple myeloma (RRMM) is a progressively refractory disease requiring chronic intensive therapy. This phase 1 study aimed to assess the safety...

Racial Disparity in the Diagnosis of Skin Cancers

Staff Writer: Andre McGowan Skin cancers are more common among the White populace, but morbidity and mortality in skin cancer is higher among Blacks and Hispanics. Skin cancers are among the most common types of cancer in the world. Most skin cancers, such as melanomas and non-melanomas, are more common in the White population, though...

Correlation of Global Longitudinal Strain With Mortality in Multiple Myeloma

Reduced global longitudinal strain indicates reduced survival in patients with multiple myeloma. Patients suffering from multiple myeloma (MM) are at significantly higher risk for developing cardiac pathology due to multiple disease- and treatment-related factors as well as old age. The prognosis for these patients can be improved by earlier detection of cardiac disease. Left ventricular...

Pomalidomide-Based Regimen for Newly Diagnosed Multiple Myeloma

Pomalidomide, bortezomib, and dexamethasone combination chemotherapy is efficacious and safe for the treatment of newly diagnosed multiple myeloma. Multiple myeloma (MM) is an incurable disease. Currently, treatment aims to improve the quality of life and overall survival of these patients. The established standard treatment in newly diagnosed multiple myeloma (NDMM) cases consists of bortezomib, lenalidomide,...

Western Diet May Have Detrimental Effect on Prostate Cancer Risk

Staff Writer: Andre McGowan Stronger diet effect seen in Gleason grade group >6 and in International Society of Urological Pathology grade 3 + 4 + 5 tumors.   Adherence to a Western diet may have a detrimental effect on the risk for prostate cancer, according to a study published online April 19 in BJU International....
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.